Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (32) | B (18) | C (20) | D (33) | E (32) | F (11) | G (7) | H (9) | I (21) | K (1) | L (23) | M (12) | N (6) | O (10) | P (25) | R (12) | S (21) | T (26) | U (2) | V (12) | Z (4)
Generic Name Common Trade Name(s) Classificationsort icon Date Marketed in Canada (yyyy/mm/dd)
Azelastine + fluticasone Dymista Antihistamine and corticosteroid agent 2015/10/22
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Canagliflozin Invokana antihyperglycemic agent 2014/06/25
Dulaglutide Trulicity Antihyperglycemic agent 2016/01/08
Albiglutide Eperzan Antihyperglycemic agent 2016/02/19
Olmesartan + hydrochlorothiazide Olmetec Plus Antihypertensive agent 2009/02
Olmesartan Olmetec Antihypertensive agent 2009/02
Azilsartan Edarbi Antihypertensive agent 2013/03/27
Azilsartan + chlorthalidone Edarbyclor Antihypertensive agent 2013/03/27
Mefloquine Lariam Antimalarial agent 2012/07/06
Lithium, sustained release Lithmax Antimanic agents
Clindamycin + tretinoin Biacna Antimicrobial + keratolytic 2010/04
Glycopyrrolate Cuvposa Antimuscarinic antispasmodic agent 2018/04/03
Degarelix Firmagon Antineoplastic agent 2009/11
Lapatinib ditosylate Tykerb Antineoplastic agent 2009/05
Azacitidine Vidaza Antineoplastic agent 2009/12/07
Everolimus Afinitor Antineoplastic agent 2010/02/12
Trabectedin Yondelis Antineoplastic agent 2010/08/04
Lenalidomide Revlimid Antineoplastic agent
Pazopanib Votrient Antineoplastic agent 2011/08/25
Ipilimumab Yervoy Antineoplastic agent 2012/03
Cabazitaxel Jevtana Antineoplastic agent 2011/06
Eribulin Halaven Antineoplastic agent 2012/03/10
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Ofatumumab Arzerra Antineoplastic agent 2012/03/09
Vemurafenib Zelboraf Antineoplastic agent 2012/02
Pertuzumab Perjeta Antineoplastic agent 2013/04/23
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Trastuzumab emtansine Kadcyla Antineoplastic agent 2013/09/27
Bendamustine Treanda Antineoplastic agent 2012/09/12
Enzalutamide Xtandi Antineoplastic agent 2013/06/07
Venetoclax Venclexta Antineoplastic agent 2016/10/31
Ixazomib Ninlaro Antineoplastic agent 2016/09/21
Avelumab Bavencio Antineoplastic agent 2017/12/18
Brigatinib Alunbrig Antineoplastic agent 2018/07/26
Cabozantinib Cabometyx Antineoplastic agent 2018/09/14
Syndicate content